Search

At Memorial Sloan Kettering Cancer Center, we have now analyzed more than 50,000 samples in our prospective cohort with MSK-IMPACT™.

… Wednesday, February 24, 2021 At Memorial Sloan Kettering Cancer Center, we have now analyzed over 65,000 samples in our prospective cohort with MSK-IMPACT™ , our next-generation sequencing (NGS) platform, and are adding to that number every day. This is up 8000 from January this year, despite Covid-19

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science.

… Monday, May 9, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10 th class of Giants of Cancer Care® for his contributions in translational science. The

Learn how immune cells in the lungs trigger invasive fungal cells to self-destruct. The discovery could produce therapies to prevent infection in cancer patients.

… Thursday, September 7, 2017 Summary Due to their weakened immune function, cancer patients who receive bone marrow transplants are at a high risk of infection from a common fungus called Aspergillus fumigatus . Researchers discovered that immune cells in the lungs of healthy people kill the fungal cells

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.

… Thursday, October 1, 2020 “It felt like watching a terrifying storm moving toward us in slow motion.” That is how Memorial Sloan Kettering lymphoma doctor Matthew Matasar describes watching the COVID-19 pandemic unfold. MSK doctors, researchers, and staff never wavered in their commitment to continue

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, December 16, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Michel Sadelain Receives Fondation ARC Léopold Griffuel Award Michel Sadelain, MD, PhD Michel Sadelain, MD, PhD , Director of the Center for Cell Engineering, and the Stephen and

After Joshy was successfully treated for pediatric kidney cancer at MSK Kids, his family signed up for Cycle For Survival to raise money for rare cancers.

… Monday, June 10, 2024 The MSK Giving community is a mighty force of hundreds of thousands of people united in a common purpose. Each has a story to tell about their reasons for giving. For Vanessa and Josh, it’s their precious son, Joshy. He was just 5 months old when he was diagnosed with a pediatric

A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy™).

… Thursday, March 8, 2012 A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy

Scientists came to MSK to celebrate the 75th birthday of a leader in the field of structural biology.

… Tuesday, May 16, 2017 Dinshaw Patel Dinshaw Patel Thomas Hermann, University of California San Diego Thomas Hermann, University of California San Diego Lawrence Shapiro, Columbia University Lawrence Shapiro, Columbia University Alexander Serganov, New York University Alexander Serganov, New York University

DeAngelis is acknowledged for her groundbreaking research in the field of neuro-oncology over her more than 30-year career.

… Friday, September 25, 2020 Memorial Sloan Kettering (MSK) is proud to announce that Physician-in-Chief and Chief Medical Officer Lisa M. DeAngelis, MD, is included on Avenue Magazine ’s The Power List 2020 . The list of more than 50 visionaries within the New York metropolitan area comprises leaders

MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.

… Tuesday, December 29, 2015 Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones. Microscopic image of a spherical organoid of intestinal cells. Taken from the blog post "Manipulating a Single Gene Turns Colorectal Cancer Cells Back to Normal." See